• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number JHJR052502J
Device Problem Insufficient Information (3190)
Patient Problems Death (1802); Dehydration (1807); Unspecified Infection (1930); Ischemia (1942); Occlusion (1984); Pneumonia (2011); Sepsis (2067); Fasciitis (2375)
Event Date 02/15/2017
Event Type  Death  
Manufacturer Narrative
The review of the manufacturing and sterilization paperwork verified that the lot met all pre-release specifications.According to the gore® viabahn® endoprosthesis instructions for use, complications associated with the use of the gore® viabahn® endoprosthesis may include but are not limited to: infection and death.(b)(4).
 
Event Description
The following was reported to gore: this patient admitted for intractable ulcer in the left lower leg (rutherford stage 6).The patient had also deep vein thrombosis.Endovascular procedure or major amputation was considered, and endovascular procedure was chosen per the family¿s request.On (b)(6) 2016, the patient underwent endovascular procedure.Angiography showed complete occlusion from the left superficial femoral artery to the left popliteal artery.A left superficial femoral artery aneurysm (measured over 20 mm) was also confirmed by pre-procedure computed tomography (ct).Therefore, the physician considered the aneurysm caused the embolic occlusion.Two gore® viabahn® endoprostheses were implanted to repair the occlusion with the aneurysm.The endoprostheses were located from the left superficial femoral artery to the distal left popliteal artery (p3 segment).It was reported that there was only one-run off vessel.Non-gore stent (epic) was implanted in the left external iliac artery.The patient tolerated the procedure.The physician reportedly said that the endovascular procedure was successfully completed, and good patency was observed after the procedure.On (b)(6) 2017, lisfranc amputation was performed in the left leg as planned.On (b)(6) 2017, split thickness skin grafting was performed for the amputated portion.Wound treatment was continued, and a condition of the skin was reportedly well.On unknown date, it was reported that the patient developed pneumonia which led to dehydration.On (b)(6) 2017, skin color of the grafted portion was not well.Acute ischemia of the left lower leg was suspected.On the same day, the physician elected to perform emergent revascularization.It was confirmed that the left superficial femoral artery was completely occluded, and thrombus aspiration was performed.A sheath was left in a place and continuous infusion of urokinase was performed.After that, ct showed emphysema in the left thigh.A diagnosis of necrotizing fasciitis was made.(the physician also reported this as gas gangrene.) on the same day, emergent above-knee amputation in the left leg was performed.Intensive care was continued, however, it was difficult to control the infection.On (b)(6) 2017, the patient developed sepsis and expired.Autopsy was not performed.The physician considered the sepsis and the patient's death were not caused by the endoprosthesis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
saori kawai
9285263030
MDR Report Key6412312
MDR Text Key70171188
Report Number2017233-2017-00130
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/18/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/17/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/02/2019
Device Catalogue NumberJHJR052502J
Device Lot Number15748181
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/02/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age79 YR
-
-